Pharmacies are experiencing a surge in demand for an anti-parasite drug. But researchers warn nearly all potential treatments simply won't work out.
as test subjects. The ivermectin study was done in test tubes, using a dose far higher than normally given to humans.
Hydroxychloroquine is available only with a prescription. A different form of the compound is sold as fish-tank cleaner. After US President Donald Trump told people to start taking the drug, one man in Arizona bought the cleaning version, took it, and died. Monash University researchers published on Friday the study showing the anti-parasite drug ivermectin could eliminate SARS-CoV-2, the virus that causes COVID-19.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Proposed COVID-19 laws to protect SA renters and hand authorities more powerCommercial and residential rent increases will be banned for six months and police powers to detain people will be bolstered under proposed coronavirus emergency laws in South Australia.
Read more »
The two factors concerning experts as new COVID-19 cases begin to fallThere were 57 new cases reported nationally on Monday, down from 139 on Sunday and 324 on Saturday, but the number of deaths surged. Are we flattening the curve? | pallavisinghal_
Read more »
Nick Kyrgios generous COVID-19 offer for help, tennis news‘Saint Nick’ has struck again.
Read more »
Coronavirus updates LIVE: Global COVID-19 cases surpass 1.2 million, Boris Johnson in intensive care unitIf you suspect you or a family member has coronavirus you should call (not visit) your GP or ring the national Coronavirus Health Information Hotline on 1800 020 080.
Read more »
Boris Johnson moved to intensive care after COVID-19 symptoms worsenBreaking Prime Minister Boris Johnson's condition has worsened since being hospitalised with persistent COVID-19 symptoms and he has been moved into intensive care, his Downing Street office says.
Read more »
Coronavirus Australia: CSL works with rivals on COVID-19 treatment from recovered patients' bloodAustralian biotechnology giant CSL Limited will work with some of its biggest rivals in the blood plasma business to try to develop a potential treatment for patients suffering complications from COVID-19.
Read more »